Clinical Trial Update: Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Vunakizumab for mild to moderate systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Vunakizumab (Vunakizumab)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Lupus Erythematosus, Systemic | Phase 1 | Status: RECRUITING